← Back to all grants

Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)

National Institutes of Health

funding_unverified
Status Published
Posted Date Jan 8, 2025
Close Date Jan 7, 2028 (Fixed)
Rural Tier Rural Eligible
Scope Nationwide
Summary

The Joint NINDS/NIMH Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects, which fall within the missions of the NINDS and NIMH. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience, or to the development of novel techniques, agents, methodologies, or models, of high value to the neuroscience community. While this funding opportunity also accepts clinical trials, only applications proposing mechanistic clinical trials or studies or basic experimental studies with humans (BESH) will be considered for funding. For information on the types of clinical trial that are within scope of this funding opportunity announcement, refer to Funding Opportunity Description, below.

Eligible Applicant Types

Not yet categorized.

Geographic Eligibility
Nationwide
Related News 5 articles
New $3.8M NIH grant funds research on 'mind after midnight' as a suicide risk factor - University of Arizona News
University of Arizona News · May 21, 2026
Recent National Institutes of Health Grant Terminations Disproportionately Impacted BIPOC Scientists - The Journal of Blacks in Higher Education
The Journal of Blacks in Higher Education · May 11, 2026
EU universities urged to consider: ‘Is NIH funding worth it?’ - Research Professional News
Research Professional News · May 8, 2026
‘Highly problematic for a thousand reasons’: NIH employees criticize Trump-era requirement to scrutinize grants with words related to diversity - Government Executive
Government Executive · May 7, 2026
Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings - National Institutes of Health (.gov)
National Institutes of Health (.gov) · May 6, 2026
Powered by Google News
🔒

Create a Free Account

Sign up to save grants, set alerts, and get personalized matches for your county — completely free.

Create Free Account I Already Have an Account